Risk Warning: CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 78% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money. Please click here to read our full Risk Warning.

78% of retail investor accounts lose money when trading CFDs with this provider.

Moderna

Moderna News

2022-crash
Friday, January 14, 2022 - 16:49
Could 2022 be the year it all comes crashing down?
pharmacy-opportunities
Friday, October 23, 2020 - 17:05
Coronavirus second wave spells opportunity as well as uncertainty

Moderna Inc (ticker MRNA; NASDAQ) is a biotech company headquartered in Cambridge, MA (USA).
The company is primarily involved in the development of "matrix-DNA" treatments for cancers and severe cardiovascular, metabolic and renal diseases.
The company was initially established in 2010 under the name "ModeRNA".
The co-founder and CEO of Moderna Inc, which employs 760 people,  is Armenian-American entrepreneur Nubar Afeyan. 

Turnover
In 2019, the company recorded more than $60 million in turnover.

Shares and listings
The company's shares are traded on the NASDAQ and are weighted in the NASDAQ Composite index. The company has 368.643M shares outstanding, with capitalisation of over $8B.

Get this report